Who
Carolyn C. Tang
General Counsel
Company insider
Files Form 4 as: General Counsel, Arcus Biosciences.
In numbers
- Trades disclosed
- 39
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $573K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 19 Jan 2021
- Last trade
- 11 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 12 Jun 2026 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code M | $88K34,090 at $2.57 | filing |
| 11 Jun 2026filed 12 Jun 2026 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | $88K34,090 at $2.57 | filing |
| 11 Jun 2026filed 12 Jun 2026 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | $88K34,090 at $2.57 | filing |
| 11 Jun 2026filed 12 Jun 2026 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code M | $88K34,090 at $2.57 | filing |
| 23 Jan 2026filed 26 Jan 2026 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 23 Jan 2026filed 26 Jan 2026 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —96,000 at $0.00 | filing |
| 23 Jan 2026filed 26 Jan 2026 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —96,000 at $0.00 | filing |
| 23 Jan 2026filed 26 Jan 2026 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 17 Dec 2025filed 18 Dec 2025 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Sold | $151K6,810 at $22.16 | filing |
| 16 Dec 2025filed 18 Dec 2025 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Sold | $168K7,658 at $21.88 | filing |
| 23 Jan 2025filed 27 Jan 2025 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 23 Jan 2025filed 27 Jan 2025 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —37,000 at $0.00 | filing |
| 15 Dec 2024filed 17 Dec 2024 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code F | $182K11,339 at $16.08 | filing |
| 15 Jun 2024filed 18 Jun 2024 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code F | $71K4,182 at $16.97 | filing |
| 23 Jan 2024filed 25 Jan 2024 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —108,200 at $0.00 | filing |
| 23 Jan 2024filed 25 Jan 2024 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code A | —26,700 at $0.00 | filing |
| 19 Dec 2023filed 20 Dec 2023 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code D | $74K4,076 at $18.09 | filing |
| 18 Dec 2023filed 20 Dec 2023 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code D | $71K3,991 at $17.74 | filing |
| 16 Jun 2023filed 16 Jun 2023 | RCUS Arcus BiosciencesBiotechnology | SEC FORM 4 Code D | $56K2,892 at $19.35 | filing |
| 23 Jan 2023filed 25 Jan 2023 | RCUS Arcus Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —138,200 at $0.00 | filing |
News
Arcus Biosciences Dips, But Recovers From Steep Losses, On Merck-Rivaling Cancer DataRCUS · investors.com · 20 Oct 2026Invivyd (NASDAQ:IVVD) and Arcus Biosciences (NYSE:RCUS) Critical ContrastRCUS · themarketsdaily.com · 19 Oct 2026Valion Bio, Inc. Common Stock (NASDAQ:VBIO) vs. Arcus Biosciences (NYSE:RCUS) Head-To-Head ComparisonRCUS · themarketsdaily.com · 18 Oct 2026
0 headlines in the last 90 days name Carolyn C. Tang; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.